This Article  • References  • Full text PDF  • Correction  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Comparison With Other H2-Receptor Antagonists

Carlo DiPadova, MD; Risto Roine, MD; Mario Frezza, MD; R. Thomas Gentry, PhD; Enrique Baraona, MD; Charles S. Lieber, MD

JAMA. 1992;267(1):83-86.

Abstract
Objective.
—To determine whether the H₂-receptor antagonist, ranitidine, which is a potent inhibitor of gastric alcohol dehydrogenase activity in vitro, increases the bioavailability of orally administered ethanol (0.3 g/kg of body weight) and to compare the resulting blood alcohol concentrations with those of two other H₂-antagonists, cimetidine and famotidine, the latter of which does not inhibit gastric alcohol dehydrogenase.

Design.
—For each of the H₂-receptor antagonists, a different group of subjects was used. In each group, a paired design was adopted with each subject serving as his own control.

Setting.
—Hospital laboratory.

Subjects.
—Normal, healthy men aged 24 to 46 years.

Intervention.
—Eight men were treated for 1 week with ranitidine (300 mg/d), six with cimetidine (1000 mg/d), and six with famotidine (40 mg/d).

Measures.
—Peak blood alcohol concentrations, areas under the blood alcohol curve, first-pass metabolism, and bioavailability of orally consumed ethanol.

Results.
—Relative to baseline, ranitidine increased the mean peak concentration and the area under the curve of blood alcohol concentrations by 34% (P<.05) and 41% (P<.01), respectively. First-pass metabolism of ethanol was decreased from 70±10 to 31±9 mg/kg of body weight, with a corresponding increase in ethanol bioavailability of 79.6% to 92.6%. By comparison, cimetidine had even a greater effect on blood alcohol levels, while famotidine had no significant effects.

Conclusion.
—Patients treated with ranitidine or cimetidine should be warned of possible functional impairments after consumption of amounts of ethanol considered safe in the absence of such therapy.

(JAMA. 1992;267:83-86)

Author Affiliations
From the Section of Liver Diseases and Nutrition and Alcohol Research and Treatment Center, Bronx Veterans Affairs Medical Center and Mount Sinai School of Medicine, New York, NY (Drs DiPadova, Roine, Gentry, Baraona, and Lieber), and the Gastroenterology and Digestive Endoscopy Unit, Hospital of Cattinara, Trieste, Italy (Dr Frezza).

Footnotes
Reprint requests to Alcohol Research and Treatment Center, Veterans Affairs Medical Center, 130W Kings-bridge Rd, Bronx, NY 10468 (Dr Lieber).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

GASTRIC ALCOHOL DEHYDROGENASE ACTIVITY IN MAN: INFLUENCE OF GENDER, AGE, ALCOHOL CONSUMPTION AND SMOKING IN A CAUCASIAN POPULATION
Parlesak et al.
Alcohol Alcohol 2002;37:388-393.
ABSTRACT | FULL TEXT  

First pass metabolism of ethanol is strikingly influenced by the speed of gastric emptying
Oneta et al.
Gut 1998;43:612-619.
ABSTRACT | FULL TEXT  

Medical Disorders of Alcoholism
Lieber
NEJM 1995;333:1058-1065.
FULL TEXT  

Pros and Cons of Over-the-Counter Availability of Histamine2-Receptor Antagonists
Feldman
Arch Intern Med 1993;153:2415-2424.
ABSTRACT  

Effects of H2-Receptor Antagonists on Blood Alcohol Levels
Fraser et al.
JAMA 1992;267:2469-2469.
ABSTRACT  

Effects of H2-Receptor Antagonists on Blood Alcohol Levels
Palmer et al.
JAMA 1992;267:2470-2470.
ABSTRACT  

Effects of H2-Receptor Antagonists on Blood Alcohol Levels
Hansten
JAMA 1992;267:2469-2470.
ABSTRACT  

Effects of H2-Receptor Antagonists on Blood Alcohol Levels
Rowland and Toon
JAMA 1992;267:2470-2470.
ABSTRACT  

RANITIDINE AND CIMETIDINE INCREASE BLOOD ALCOHOL LEVELS
JWatch General 1992;1992:2-2.
FULL TEXT